Using propensity scores to estimate effects of treatment initiation decisions: State of the science-Reference-Cited by-同舟云学术

Using propensity scores to estimate effects of treatment initiation decisions: State of the science

Published:2020-12-29 Issue:7 Volume:40 Page:1718-1735
ISSN:0277-6715
Container-title:Statistics in Medicine
language:en
Short-container-title:Statistics in Medicine

Author:

Webster‐Clark Michael¹^ORCID,Stürmer Til¹,Wang Tiansheng¹,Man Kenneth²³,Marinac‐Dabic Danica⁴,Rothman Kenneth J.⁵⁶,Ellis Alan R.⁷,Gokhale Mugdha¹⁸,Lunt Mark⁹,Girman Cynthia¹¹⁰,Glynn Robert J.¹¹

Affiliation:

1. Department of Epidemiology UNC Chapel Hill Chapel Hill North Carolina USA

2. Research Department of Practice and Policy UCL School of Pharmacy London UK

3. Department of Pharmacology and Pharmacy, LKS Faculty of Medicine University of Hong Kong Hong Kong

4. Office of Clinical Evidence and Analysis FDA Center for Devices and Radiological Health Silver Springs Maryland USA

5. RTI Health Solutions Raleigh North Carolina USA

6. Department of Epidemiology Boston University Boston Massachusetts USA

7. Department of Social Work NC State University Raleigh North Carolina USA

8. Pharmacoepidemiology, Center for Observational & Real‐World Evidence Merck West Point Pennsylvania USA

9. The Arthritis Research UK Epidemiology Unit University of Manchester Manchester UK

10. CERobs Consulting, LLC Chapel Hill North Carolina USA

11. Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital Harvard Medical School Boston Massachusetts USA

Funder

National Institute on Aging

Publisher

Wiley

Subject

Statistics and Probability,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/sim.8866

Reference137 articles.

1. Confounding in Health Research

2. FDA.Real World Evidence.2018.https://www.fda.gov/science‐research/science‐and‐research‐special‐topics/real‐world‐evidence. Accessed August 6 2019.

3. Data Rich, Information Poor: Can We Use Electronic Health Records to Create a Learning Healthcare System for Pharmaceuticals?

4. Smoking and lung cancer: recent evidence and a discussion of some questions;Cornfield J;J Natl Cancer Inst,1959

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overcoming the discrepancies between RCTs and real-world data by accounting forSelection criteria, Operations, andMeasurements of Outcome (SOMO);2024-01-23

2. Glucagon-like peptide-1 receptor agonists and the risk of atrial fibrillation in adults with diabetes: a real-world study;Journal of General Internal Medicine;2024-01-08

3. Framework for the Use of External Controls to Evaluate Treatment Outcomes in Precision Oncology Trials;JCO Precision Oncology;2024-01

4. The Impact of Inter-Cycle Treatment Delays on 5-Year All-Cause Mortality in Early-Stage Breast Cancer;2024

5. Neoadjuvant Chemotherapy With/Without Radiotherapy for Locally Advanced Rectal Cancer: A Nationwide Retrospective Cohort Study;Anticancer Research;2023-11-29